BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17239234)

  • 21. Establishment of tetracycline-inducible gene expression systems in the silkworm, Bombyx mori.
    Karasaki N; Mon H; Takahashi M; Lee JM; Koga K; Kawaguchi Y; Kusakabe T
    Biotechnol Lett; 2009 Apr; 31(4):495-500. PubMed ID: 19066730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Tet-On" system toward hepatic differentiation of human mesenchymal stem cells by hepatocyte nuclear factor.
    Shiota G; Yoshida Y
    Methods Mol Biol; 2012; 826():125-32. PubMed ID: 22167645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines.
    Benabdellah K; Cobo M; Muñoz P; Toscano MG; Martin F
    PLoS One; 2011; 6(8):e23734. PubMed ID: 21876765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-chain Tet transregulators.
    Krueger C; Berens C; Schmidt A; Schnappinger D; Hillen W
    Nucleic Acids Res; 2003 Jun; 31(12):3050-6. PubMed ID: 12799431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditional expression in the malaria mosquito Anopheles stephensi with Tet-On and Tet-Off systems.
    Lycett GJ; Kafatos FC; Loukeris TG
    Genetics; 2004 Aug; 167(4):1781-90. PubMed ID: 15342516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch.
    Wells KD; Foster JA; Moore K; Pursel VG; Wall RJ
    Transgenic Res; 1999 Oct; 8(5):371-81. PubMed ID: 10669945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binary AdEasy vector systems designed for Tet-ON or Tet-OFF regulated control of transgene expression.
    Berenjian S; Akusjärvi G
    Virus Res; 2006 Jan; 115(1):16-23. PubMed ID: 16102868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tet repressor induction by tetracycline: a molecular dynamics, continuum electrostatics, and crystallographic study.
    Aleksandrov A; Schuldt L; Hinrichs W; Simonson T
    J Mol Biol; 2008 May; 378(4):898-912. PubMed ID: 18395746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy on demand: site specific regulation of gene therapy.
    Jazwa A; Florczyk U; Jozkowicz A; Dulak J
    Gene; 2013 Aug; 525(2):229-38. PubMed ID: 23566848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.
    Bornkamm GW; Berens C; Kuklik-Roos C; Bechet JM; Laux G; Bachl J; Korndoerfer M; Schlee M; Hölzel M; Malamoussi A; Chapman RD; Nimmerjahn F; Mautner J; Hillen W; Bujard H; Feuillard J
    Nucleic Acids Res; 2005 Sep; 33(16):e137. PubMed ID: 16147984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetracycline-controlled genetic switches.
    Sprengel R; Hasan MT
    Handb Exp Pharmacol; 2007; (178):49-72. PubMed ID: 17203651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two mutations in the tetracycline repressor change the inducer anhydrotetracycline to a corepressor.
    Kamionka A; Bogdanska-Urbaniak J; Scholz O; Hillen W
    Nucleic Acids Res; 2004; 32(2):842-7. PubMed ID: 14764926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2.
    Welman A; Barraclough J; Dive C
    Nat Protoc; 2006; 1(2):803-11. PubMed ID: 17406311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector.
    Strathdee CA; McLeod MR; Hall JR
    Gene; 1999 Mar; 229(1-2):21-9. PubMed ID: 10095100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of 5' sequences on expression of the Tet repressor in Giardia lamblia.
    Sun CH; Su LH; Gillin FD
    Mol Biochem Parasitol; 2005 Jul; 142(1):1-11. PubMed ID: 15907557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tet repressor mutants with altered effector binding and allostery.
    Henssler EM; Bertram R; Wisshak S; Hillen W
    FEBS J; 2005 Sep; 272(17):4487-96. PubMed ID: 16128817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral evolution as a tool to improve the tetracycline-regulated gene expression system.
    Das AT; Zhou X; Vink M; Klaver B; Verhoef K; Marzio G; Berkhout B
    J Biol Chem; 2004 Apr; 279(18):18776-82. PubMed ID: 14761948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloom's syndrome gene-deficient phenotype in mouse primary cells induced by a modified tetracycline-controlled trans-silencer.
    Hayakawa T; Yusa K; Kouno M; Takeda J; Horie K
    Gene; 2006 Mar; 369():80-9. PubMed ID: 16387452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel positive tetracycline-dependent transactivator (rtTA) variant with reduced background activity and enhanced activation potential.
    Kämper MR; Gohla G; Schlüter G
    FEBS Lett; 2002 Apr; 517(1-3):115-20. PubMed ID: 12062420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae.
    Kushnir S; Gase K; Breitling R; Alexandrov K
    Protein Expr Purif; 2005 Jul; 42(1):37-46. PubMed ID: 15939291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.